NOD2/CARD15 does not influence response to infliximab in Crohn's disease

Vermeire, S.; Louis, Edouard; Rutgeerts, P.; De Vos, M.; Van Gossum, A.; Belaiche, Jacques; Pescatore, Pierre; Fiasse, R.; Pelckmans, P.; Vlietinck, R.; Merlin, F.; Zouali, H.; Thomas, G.; Colombel, J. F.; Hugot, J. P.

doi:10.1053/gast.2002.34172

Download

Article (Scientific journals)

NOD2/CARD15 does not influence response to infliximab in Crohn's disease

Vermeire, S.; Louis, Edouard; Rutgeerts, P. et al.

2002 • In Gastroenterology, 123 (1), p. 106-111

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/26419

DOI
10.1053/gast.2002.34172

PubMed
12105838

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

NOD2-CARD15 Does Not Influence Response... 2002 traité OCR.pdf

Author postprint (190.05 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Abstract :

[en] Background

Disciplines :

Gastroenterology & hepatology

Author, co-author :

Vermeire, S.

Louis, Edouard ; Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie

Rutgeerts, P.

De Vos, M.

Van Gossum, A.

Belaiche, Jacques ; Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie

Pescatore, Pierre ; Université de Liège - ULiège > Relations académiques et scientifiques (Droit)

Fiasse, R.

Pelckmans, P.

Vlietinck, R.

More authors (5 more)

Language :

English

Title :

NOD2/CARD15 does not influence response to infliximab in Crohn's disease

Publication date :

July 2002

Journal title :

Gastroenterology

ISSN :

0016-5085

eISSN :

1528-0012

Publisher :

W B Saunders Co, Philadelphia, United States - Pennsylvania

Volume :

123

Issue :

Pages :

106-111

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 26 October 2009

Statistics

Number of views

93 (0 by ULiège)

Number of downloads

314 (0 by ULiège)

More statistics

Scopus citations^®

228

Scopus citations^®
without self-citations

192

OpenCitations

167

OpenAlex citations

212

publications

supporting

mentioning

contrasting

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Bibliography

Calkins B.M., Mendelhoff A.I. (1995) The epidemiology of idiopathic inflammatory bowel disease. Inflammatory bowel disease. 4th ed , Kirsner JB, Shorter RG, eds. Baltimore: Williams & Wilkins; 31-68.
Binder V. (1998) Genetic epidemiology in inflammatory bowel disease. Dig Dis 16:351-355.
Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O’Morain C., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.F., Sahbatou M., Thomas G. (2001) Association of NOD2/CARD15 leucin-rich repeat variants with susceptibility to Crohn disease. Nature 411:599-603.
Ogura Y., Bonen D.K., Inohara N., Nicolae D.I., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., Achkar J.P., Brant S.R., Bayless T.M., Kirschner B.S., Hanauer S.B., Nunez G., Cho J.H. (2001) A frameshift mutation in NOD2/CARD15 associated with susceptibility to Crohn disease. Nature 411:603-606.
Ogura Y., Inohara N., Benito A., Chen F.F., Yamaoka S., Nunez G. (2001) NOD2/CARD15, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB. J Biol Chem 276:4812-4818.
Targan S.R., Hanauer S.B., Van Deventer S.J.H., Mayer L., Present D.H., Braakman T.A.J., DeWoody K.L., Schaible T.F., Rutgeerts P. (1997) A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn disease. N Engl J Med 337:1029-1035.
Present D.H., Rutgeerts P., Targan S., Hanauer S.B., Mayer L., Van Hogezand R.A., Podolsky D.K., Sands B.E., Braakman T., DeWoody K.L., Schaible T.F., Van Deventer S.J. (1999) Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med 340:1398-1405.
Rutgeerts P., D’Haens G., Targan S., Vasiliauskas E., Hanauer S.B., Present D.H., Mayer L., Van Hogezand R.A., Braakman T., DeWoody K.L., Schaible T.F., Van Deventer S.J.H. (1999) Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn’s disease. Gastroenterology 117:761-769.
Mascheretti S., Hampe J., Sfikas N., Kuhbacher T., Andus T., Herfarth H., Foelsch U., Scheiber S. (2001) Pharmcacogenetic association between the TNF receptor 2 genotype and response to infliximab treatment in Crohn’s disease. Gastroenterology 120:A362.
Taylor K.D., Plevy S.E., Yang H., Landers C.J., Barry M.J., Rotter J.I., Targan S.R. (2001) ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn’s disease. Gastroenterology 120:1347-1355.
Hampe J., Cuthbert A., Croucher P.J.P., Mirza M.M., Mascheretti S., Fisher S., Frenzel H., King K., Hasselmeyer A., MacPherson A.J.S., Bridger S., Van Deventer S., Forbers A., Nikolaus S., Lennard-Jones J.E., Foelsch U.R., Krawczak M., Lewis C., Schreiber S., Mathew C.G. (2001) Association between insertion mutation in NOD2/CARD15 gene and Crohn’s disease in German and British populations. Lancet 357:1925-1928.
Wardle T.D., Hall L., Turnberg L.A. (1992) Use of coculture of colonic biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel disease. Gut 33:1644-1651.
Riley S.A., Mani V., Goodman M.J., Dutt S., Herd M.E. (1991) Microscopic activity in ulcerative colitis: What does it mean?. Gut 32:174-178.
Reimund J.M., Wittersheim C., Dumont S., Muller C.D., Kennet J.S., Baumann R., Poindron P., Duclos B. (1996) Increased production of tumor necrosis factor-α, interleukin-β, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn’s disease. Gut 39:684-689.
Hugot J.P., Laurent-Puig P., Gower-Rousseau C., Olson J.M., Lee J.C., Beaugerie L., Naom I., Dupas J.L., Van Gossum A., Orholm M., Bonaiti-Pellie C., Weissenbach J., Mathew C.G., Lennard-Jones J.E., Cortot A., Colombel J.F., Thomas G. (1996) Mapping of a susceptibility locus for Crohn’s disease on chromosome 16. Nature 379:821-823.

Similar publications

Sorry the service is unavailable at the moment. Please try again later.

Name	Provider / Domaine	Expiration	Description
JSESSIONID	Oracle Corporation www.uliege.be	Session	General purpose platform session cookie, used by sites written in JSP. Usually used to maintain an anonymous user session by the server.
CookieScriptConsent	CookieScript .uliege.be	1 year	This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.

Name	Provider / Domaine	Expiration	Description
_pk_id	InnoCraft Ltd .uliege.be	1 year	Used to store a few details about the user such as the unique visitor ID
_pk_ses	InnoCraft Ltd .uliege.be	30 minutes	Short lived cookies used to temporarily store data for the visit
_pk_ref	InnoCraft Ltd .uliege.be	6 months	Used to store the attribution information, the referrer initially used to visit the website